Form 4 Tracker
Jill Carroll

Director · 2 filings · Latest: May 1, 2026

Arcellx, Inc.
Avalyn Pharma Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
AVLN
Jill CarrollDirectorMay 1, 2026
Purchase
$18.00277,778$5.0M2,186,562
AVLN
Jill CarrollDirectorMay 1, 2026
Conversion
1,908,7841,908,784
ACLX
Jill CarrollDirectorApr 28, 2026
U
1,479,1480